Me NaPhos MB Hyo 1 Tablets and Oxymorphone Hydrochloride
Determining the interaction of Me NaPhos MB Hyo 1 Tablets and Oxymorphone Hydrochloride and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using oxyMORphone together with methylene blue may rarely increase the risk of serious side effects such as respiratory depression, low blood pressure, fainting, coma, and even death. In general, it is best to wait at least 14 days after stopping methylene blue before you start treatment with oxyMORphone. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should avoid the use of alcohol while being treated with these medications. Also avoid driving or operating hazardous machinery until you know how your medications affect you, and do not exceed the dosage or frequency of use prescribed by your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Coadministration of narcotic analgesics with monoamine oxidase inhibitors (MAOIs) has been associated with rare reports of anxiety, confusion, hypotension, respiratory depression, cyanosis, and coma. The mechanism of interaction is unknown, but may involve potentiation of central nervous system (CNS) and respiratory depressant effects by MAOIs. Concomitant use of pentazocine with MAOIs may also cause CNS excitation and hypertension through their respective effects on catecholamines.
MANAGEMENT: Narcotic analgesics should generally not be used with MAOIs or other agents that possess MAOI activity (e.g., furazolidone, linezolid, methylene blue, procarbazine). At least 14 days should elapse between discontinuation of MAOI therapy and initiation of treatment with opioids. However, morphine has been safely used in MAOI-treated patients who previously had an adverse reaction with meperidine and is generally suggested as an alternative to meperidine in anesthesia. A sensitivity test should be performed in which repeated, small, incremental doses of morphine are administered over the course of several hours while overall clinical status and vital signs are carefully monitored.
- "Product Information. Tylenol with Codeine (acetaminophen-codeine)." Janssen Pharmaceuticals, Raritan, NJ.
- "Product Information. Emsam (selegiline)." Bristol-Myers Squibb, Princeton, NJ.
- Zornberg GL, Hegarty JD "Adverse interaction between propoxyphene and phenelzine." Am J Psychiatry 150 (1993): 1270-1
- Michaels I, Serrins M, Shier NQ, Barash PG "Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors." Anesth Analg 63 (1984): 1041-4
- Evans-Prosser CD "The use of pethidine and morphine in the presence of monoamine oxidase inhibitors." Br J Anaesth 40 (1968): 279-82
- "Product Information. Parnate (tranylcypromine)." SmithKline Beecham, Philadelphia, PA.
- "Product Information. Buprenex (buprenorphine)." Reckitt and Colman Pharmaceutical, Richmond, VA.
- "Product Information. Talacen (acetaminophen-pentazocine)." Sanofi-Synthelabo Inc, New York, NY.
- "Product Information. Roxicodone (oxycodone)." Roxane Laboratories Inc, Columbus, OH.
- "Product Information. Marplan (isocarboxazid)" Roche Laboratories, Nutley, NJ.
- "Product Information. Nubain (nalbuphine)." Endo Laboratories, Texarkana, TX.
- "Product Information. MS Contin (morphine)." Purdue Frederick Company, Norwalk, CT.
- "Product Information. Levo-Dromoran (levorphanol)." Roche Laboratories, Nutley, NJ.
- Garbutt JC "Potentiation of propoxyphene by phenelzine." Am J Psychiatry 144 (1987): 251-2
- "Product Information. Nardil (phenelzine)." Parke-Dvis, Morris Plains, NJ.
- Browne B, Linter S "Monoamine oxidase inhibitors and narcotic analgesics: a critical review of the implications for treatment." Br J Psychiatry 151 (1987): 210-2
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Me NaPhos MB Hyo 1 Tablets-Oxymorphone Injection
- Me NaPhos MB Hyo 1 Tablets-Oxymorphone Tablets
- Me NaPhos MB Hyo 1 Tablets-Oxytocin
- Me NaPhos MB Hyo 1 Tablets-Oxytocin Intravenous, Intramuscular
- Me NaPhos MB Hyo 1 Tablets-Oxytrol
- Me NaPhos MB Hyo 1 Tablets-Oystercal-D
- Oxymorphone Hydrochloride-ME-500
- Oxymorphone Hydrochloride-Me-PB-Hyos Elixir
- Oxymorphone Hydrochloride-Me-PB-Hyos Tablets
- Oxymorphone Hydrochloride-ME/NaPhos/MB/Hyo1
- Oxymorphone Hydrochloride-Measles and rubella virus vaccine live Intramuscular, Injection
- Oxymorphone Hydrochloride-Measles virus vaccine, live Subcutaneous